首页> 外文OA文献 >Genetic polymorphisms of the main transcription factors for adiponectin gene promoter in regulation of adiponectin levels: association analysis in three European cohorts.
【2h】

Genetic polymorphisms of the main transcription factors for adiponectin gene promoter in regulation of adiponectin levels: association analysis in three European cohorts.

机译:脂联素基因启动子主要转录因子在调节脂联素水平上的遗传多态性:三个欧洲队列的关联分析。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Adiponectin serum concentrations are an important biomarker in cardiovascular epidemiology with heritability etimates of 30-70%. However, known genetic variants in the adiponectin gene locus (ADIPOQ) account for only 2%-8% of its variance. As transcription factors are thought to play an under-acknowledged role in carrying functional variants, we hypothesized that genetic polymorphisms in genes coding for the main transcription factors for the ADIPOQ promoter influence adiponectin levels. Single nucleotide polymorphisms (SNPs) at these genes were selected based on the haplotype block structure and previously published evidence to be associated with adiponectin levels. We performed association analyses of the 24 selected SNPs at forkhead box O1 (FOXO1), sterol-regulatory-element-binding transcription factor 1 (SREBF1), sirtuin 1 (SIRT1), peroxisome-proliferator-activated receptor gamma (PPARG) and transcription factor activating enhancer binding protein 2 beta (TFAP2B) gene loci with adiponectin levels in three different European cohorts: SAPHIR (n = 1742), KORA F3 (n = 1636) and CoLaus (n = 5355). In each study population, the association of SNPs with adiponectin levels on log-scale was tested using linear regression adjusted for age, sex and body mass index, applying both an additive and a recessive genetic model. A pooled effect size was obtained by meta-analysis assuming a fixed effects model. We applied a significance threshold of 0.0033 accounting for the multiple testing situation. A significant association was only found for variants within SREBF1 applying an additive genetic model (smallest p-value for rs1889018 on log(adiponectin) = 0.002, β on original scale = -0.217 µg/ml), explaining ∼0.4% of variation of adiponectin levels. Recessive genetic models or haplotype analyses of the FOXO1, SREBF1, SIRT1, TFAPB2B genes or sex-stratified analyses did not reveal additional information on the regulation of adiponectin levels. The role of genetic variations at the SREBF1 gene in regulating adiponectin needs further investigation by functional studies.
机译:脂联素血清浓度是心血管流行病学中重要的生物标志物,遗传率估计为30-70%。但是,脂联素基因位点(ADIPOQ)中已知的遗传变异仅占其变异的2%-8%。由于人们认为转录因子在携带功能性变异中起不到公认的作用,因此我们假设编码ADIPOQ启动子主要转录因子的基因中的遗传多态性会影响脂联素水平。这些基因的单核苷酸多态性(SNPs)是根据单倍型嵌段结构和先前发表的与脂联素水平相关的证据选择的。我们对叉头箱O1(FOXO1),固醇调节元件结合转录因子1(SREBF1),sirtuin 1(SIRT1),过氧化物酶体增殖物激活受体γ(PPARG)和转录因子的24个选定SNP进行了关联分析在三个不同的欧洲人群中,具有脂联素水平的活化增强子结合蛋白2 beta(TFAP2B)基因位点:SAPHIR(n = 1742),KORA F3(n = 1636)和CoLaus(n = 5355)。在每个研究人群中,使用线性回归分析校正了SNPs与脂联素水平的对数关系,校正了年龄,性别和体重指数,同时应用了加性和隐性遗传模型。通过荟萃分析(假设一个固定效应模型)获得了合并效应量。考虑到多重测试的情况,我们应用了0.0033的显着性阈值。仅在应用附加遗传模型的SREBF1中发现了显着关联(rs1889018的最小p值在log(脂联素)= 0.002,β在原始比例= -0.217 µg / ml),解释了脂联素变异的〜0.4%水平。 FOXO1,SREBF1,SIRT1,TFFAB2B基因的隐性遗传模型或单倍型分析或性别分层分析均未揭示脂联素水平调控的其他信息。 SREBF1基因的遗传变异在调节脂联素中的作用需要通过功能研究进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号